You have 9 free searches left this month | for more free features.

Severe Acute Respiratory Syndrome (SARS) Pneumonia

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Coronavirus, COVID-19, SARS-CoV Infection Trial in Freiburg (vv-ECMO + cytokine adsorption (Cytosorb adsorber), vv-ECMO only (no

Completed
  • Coronavirus
  • +4 more
  • vv-ECMO + cytokine adsorption (Cytosorb adsorber)
  • vv-ECMO only (no cytokine adsorption)
  • Freiburg, Germany
    University Clinic Freiburg
Mar 11, 2021

Severe Acute Respiratory Syndrome (SARS) Pneumonia, Coronavirus Infections, ARDS, Human Trial in Trieste (Methylprednisolone,

Completed
  • Severe Acute Respiratory Syndrome (SARS) Pneumonia
  • +2 more
  • Trieste, TS, Italy
    Marco Confalonieri
Jun 23, 2020

Covid19, SARS-CoV Infection Trial in Chía (Clinical follow-up for 24 months)

Not yet recruiting
  • Covid19
  • SARS-CoV Infection
  • Clinical follow-up for 24 months
  • Chía, Cundinamarca, Colombia
    Clinica Universidad De La Sabana
Jun 21, 2021

Clinical Impact of COVID-19 by P.1 SARS-CoV-2 Lineage

Completed
  • Covid19
  • +2 more
  • No intervention performed
  • Porto Alegre, RS, Brazil
    Hospital de Clínicas de Porto Alegre
Jul 16, 2021

Severity of Severe Acute Respiratory Syndrome COVID-19 Infection

Completed
  • COVID-19
  • +3 more
  • No Intervention
  • Colton, California
    Arrowhead Regional Medical Center
Jun 7, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Pneumonia Trial in United States (Tocilizumab)

Terminated
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +5 more
  • Tocilizumab
  • Rockville, Maryland
  • +4 more
Jul 16, 2021

Extra Vascular Lung Water and Pulmonary Permeability in

Completed
  • COVID-19
  • +2 more
    • Montpellier, France
      Uhmontpellier
    Dec 28, 2020

    Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Ferrara (SARS-Cov-2 infection)

    Recruiting
    • Severe Acute Respiratory Syndrome Coronavirus 2
    • SARS-Cov-2 infection
    • Ferrara, Italy
      Azienda Ospedaliera Universitaria di Ferrara
    Nov 1, 2022

    Acute Respiratory Distress Syndrome, Infections Trial (Rhu-pGSN, normal saline)

    Not yet recruiting
    • Acute Respiratory Distress Syndrome
    • Infections
    • (no location specified)
    Jul 16, 2023

    Covid19, SARS-CoV Infection, Pneumonia, Viral Trial in Modena (Enoxaparin, Methylprednisolone, unfractionated heparin)

    Recruiting
    • Covid19
    • +3 more
    • Modena, Italy
      ICU- University Hospital Modena
    May 3, 2021

    Dyspnea Trial in Paris, Argenteuil (Specific exercise rehabilitation treatment, No specific exercise rehabilitation treatment)

    Active, not recruiting
    • Dyspnea
    • Specific exercise rehabilitation treatment
    • No specific exercise rehabilitation treatment
    • Paris, Ile-de-France, France
    • +2 more
    Aug 3, 2022

    Assess Infection Rate of Severe Acute Respiratory Syndrome -

    Completed
    • Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)
      • Chicago, Illinois
        Great Lakes Clinical Trials /ID# 224874
      Oct 6, 2022

      Initial CT Findings and CO-RADS Stage in COVID-19

      Completed
      • Covid19
      • +2 more
        • Istanbul, Turkey
        • +1 more
        Jun 4, 2021

        Chest X-ray Severity Scoring System of COVID-19 Pneumonia

        Recruiting
        • COVID-19 Pneumonia
        • +4 more
        • Chest X-ray
        • Osijek, Croatia
          University hospital Osijek
        Apr 25, 2022

        COVID, Covid-19, Corona Virus Infection Trial in Ventura (ResCure™)

        Withdrawn
        • COVID
        • +6 more
        • ResCure™
        • Ventura, California
          ProgenaBiome
        Apr 6, 2021

        SARS (Severe Acute Respiratory Syndrome), Coronavirus Trial in Sweden, United States (Nitric Oxide Gas)

        Completed
        • SARS (Severe Acute Respiratory Syndrome)
        • Coronavirus
        • Nitric Oxide Gas
        • Birmingham, Alabama
        • +4 more
        Jun 20, 2022

        Acute Respiratory Distress Syndrome Trial (Itolizumab)

        Not yet recruiting
        • Acute Respiratory Distress Syndrome
        • (no location specified)
        Aug 3, 2023

        Non-invasive Oxygenation Strategies in Patients Admitted for

        Completed
        • Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
        • Use of High Flow Nasal Cannula alone
        • +2 more
        • Béthune, Nord-Pas-de-Calais, France
        • +3 more
        Oct 10, 2022

        Severe Acute Respiratory Syndrome Coronavirus 2, Severe Acute Respiratory Distress Syndrome Trial in Paris (Umbilical cord

        Completed
        • Severe Acute Respiratory Syndrome Coronavirus 2
        • Severe Acute Respiratory Distress Syndrome
        • Umbilical cord Wharton's jelly-derived human
        • NaCl 0.9%
        • Paris, France
        • +1 more
        Feb 17, 2022

        Antigen Rapid Diagnostic Tests for Community Identification of

        Recruiting
        • Severe Acute Respiratory Syndrome Coronavirus 2 Infection
        • Rapid Antigen Testing
        • Kiambu, Kenya
          Kiambu County
        Jul 12, 2022

        Severe Exacerbation of Severe Acute Respiratory Syndrome

        Active, not recruiting
        • SARS-CoV-2
          • Tokyo, Japan
            CMIC Co. Ltd.,
          Jun 5, 2023

          Japan After Severe Acute Respiratory Syndrome Coronavirus 2

          Not yet recruiting
          • SARS-CoV-2
            • Tokyo, Japan
              CMIC Co., Ltd
            Jun 6, 2023

            Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

            Not yet recruiting
            • Systemic Sclerosis
            • SARS-CoV 2 Vaccination
              • (no location specified)
              Jul 24, 2023

              Covid19, Hypertension, Corona Persistent Symptoms Trial in Giza (Inspiratory muscle trainer, diaphragmatic release)

              Enrolling by invitation
              • Covid19
              • +2 more
              • Inspiratory muscle trainer
              • diaphragmatic release
              • Giza, Dokki, Egypt
                Faculty of Physical Therapy
              Jun 17, 2022

              SARS-CoV 2, COVID, ARDS Trial (ZYESAMI™ (aviptadil acetate), Placebo, Nebulized administration of ZYESAMI™ or Placebo)

              Withdrawn
              • SARS-CoV 2
              • +5 more
              • ZYESAMI™ (aviptadil acetate)
              • +2 more
              • (no location specified)
              Feb 2, 2023